Analysts downplay Medicare cost-cutting impact on Dexcom as shares drop 5%
Go back to Analysts downplay Medicare cost-cutting impact on Dexcom as shares drop 5%| Abbott Laboratories (NYSE: ABT) | Delayed: 101.29 +0.22 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $101.07 | 52 Week High | $46.38 | |||
| Open | $100.81 | 52 Week Low | $36.00 | |||
| Day High | $101.82 | P/E | 67.53 | |||
| Day Low | $100.09 | EPS | $1.50 | |||
| Volume | 7,774,692 | |||||
| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 86.62 -0.85 (0.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.47 | 52 Week High | $96.38 | |||
| Open | $87.38 | 52 Week Low | $47.92 | |||
| Day High | $87.64 | P/E | N/A | |||
| Day Low | $86.36 | EPS | $-0.42 | |||
| Volume | 1,875,538 | |||||
